Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2023 - 10:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential, for Use
of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional
Materials |
☐ |
Soliciting Material
Pursuant to §240.14a-12 |
VIVANI
MEDICAL, INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
☒ |
No fee required. |
☐ |
Fee computed
on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
|
|
(1) |
Title of each class
of securities to which transaction applies: |
|
(2) |
Aggregate number of
securities to which transaction applies: |
|
(3) |
Per unit price or other
underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined); |
|
(4) |
Proposed maximum aggregate
value of transaction: |
|
(5) |
Total fee paid: |
☐ |
Fee
paid previously with preliminary materials. |
☐ |
Check box
if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing. |
|
(1) |
Amount
Previously Paid: |
|
(2) |
Form,
Schedule or Registration Statement No.: |
|
(3) |
Filing
Party: |
|
(4) |
Date
Filed: |
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Dec 2024 to Jan 2025
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Second Sight Medical Products Inc (NASDAQ): 0 recent articles
More Vivani Medical, Inc. News Articles